200-541-4

Applied Filters:

Keyword:'200-541-4'

Showing 1-2 of 2 results for "200-541-4" within Papers

Targeted mutational analysis of ankyrin-B in 541 consecutive, unrelated patients referred for long QT syndrome genetic testing and 200 healthy subjects.

Jonathan Sherman et al.

Heart rhythm, 2(11), 1218-1223 (2005-10-29)

Mutations in ANK2-encoded ankyrin-B underlie long QT syndrome type 4 (LQT4) and various other dysrhythmia phenotypes. The purpose of this study was to determine the prevalence and spectrum of ankyrin-B mutations in a large cohort of unrelated patients referred for

Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity.

Omar N Al Safarjalani et al.

Cancer chemotherapy and pharmacology, 69(6), 1449-1455 (2012-03-01)

The purpose of this investigation was to evaluate the effectiveness of oral 5-(phenylthio)acyclouridine (PTAU) in reducing 5-fluorouracil (FUra) host toxicity and enhancing its chemotherapeutic efficacy against human breast tumors. PTAU is a potent and specific inhibitor of uridine phosphorylase (UP

Page 1 of 1